The
microfibrillar protein fibrillin-1 is a component of the mesangial matrix. Defects in
fibrillin-1 predisposes individuals to vascular damage in
Marfan syndrome, but the role of
fibrillin-1 in
kidney disease is unknown. We hypothesized that
fibrillin-1 is involved in hypertensive or diabetic glomerular disease.
DOCA-
salt hypertension or
streptozotocin (STZ) diabetes led to a significant increase in glomerular
fibrillin-1 deposition. To test the functional role of
fibrillin-1,
DOCA hypertension and STZ diabetes were induced in mice homozygous for a mutation leading to a fivefold lower expression of
fibrillin-1 (mgR/mgR). Untreated male mgR/mgR mice usually die from
aortic dissection during the first 4 mo of life. All
DOCA-treated mgR/mgR mice died within 2 wk after onset of
DOCA treatment.
DOCA-treated heterozygous (mgR/+) and their wild-type littermates displayed similar blood pressure levels, but
albuminuria was significantly lower in mgR/+ than in wild-type mice after
DOCA treatment. Similarly, STZ diabetic mgR/mgR and mgR/+ developed lower
albuminuria than wild-type mice despite higher
blood glucose levels in mgR/mgR and mgR/+ compared with wild-type mice. Blood pressure,
blood glucose, and
albuminuria did not differ among untreated mgR/mgR, mgR/+, and wild-type mice, respectively. In diabetic mgR/+ and mgR/mgR, but not in wild-type mice, an induction of glomerular
decorin expression was observed. Thus underexpression of
fibrillin-1 predisposes individuals to lethal
aortic dissection in the presence of
hypertension. On the other hand,
albuminuria as a parameter of microvascular damage in
hypertension and diabetes was ameliorated in fibrillin-1-underexpressing mice, possibly due to a compensatory upregulation of
decorin. We conclude that
fibrillin-1 may contribute to glomerular damage in hypertensive and
diabetic kidney disease.